Komori
Haba Laboratories (4925) · InitiativeAdvanced

Expanding wholesale channels and strengthening joint development, private-label and OEM businesses

First written in FY2016. 20 of 25 entries say "Restated". Latest entry: FY2026.

25entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2024-Q32016: 320162017: 320172018: 420182019: 420192020: 420202021: 220212022: 220222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies

24 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 48 companies compared. The sentences above are computed from all 48.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「In Other Wholesale Business (domestic wholesale business and overseas wholesale business), domestic operations were affected by store closures by major customers and a decline in large orders, while overseas shipment volumes increased as sales efficiency improved through consolidation of the Chinese distributor network, resulting in sales of ¥2,895.239 million, up 10.1% from the previous fiscal year.」

    Improved sales efficiency from consolidating the Chinese distributor network into a single distributor contributed to full-year overseas wholesale growth, and Other Wholesale Business sales increased 10.1% year on year.
  2. FY2026-H1AdvancedAnnual report

    「In Other Wholesale Business (domestic wholesale business and overseas wholesale business), domestic sales declined due to the closure of stores operated by major customers and a decrease in large orders. Overseas, sales efficiency improved after consolidating the Chinese distributor network into a single distributor from April 2025, and shipments to China increased substantially, resulting in sales of ¥1,462.422 million, up 10.6% year on year.」

    The company consolidated its Chinese distributors into a single distributor from April 2025, improving sales efficiency and increasing shipments to China. Other wholesale sales increased 10.6% year on year.
  3. FY2024-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  4. FY2023-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  5. FY2022-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  6. FY2022-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  7. FY2021-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  8. FY2021-Q2RestatedAnnual report

    「There were no significant changes during the second quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  9. FY2021-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  10. FY2020RestatedAnnual report

    「H Plus B Life Science Co., Ltd. will also actively pursue securing sales channels for its products.」

    The company continues to pursue securing sales channels for products from H Plus B Life Science.
  11. FY2020-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  12. FY2020-Q2RestatedAnnual report

    「There were no significant changes during the second quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  13. FY2020-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  14. FY2019RestatedAnnual report

    「H Plus B Life Science Co., Ltd. will also actively pursue securing sales channels for its products.」

    The company continues to pursue securing sales channels for products from H Plus B Life Science.
  15. FY2019-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  16. FY2019-Q2RestatedAnnual report

    「There were no significant changes during the second quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  17. FY2019-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  18. FY2018SoftenedAnnual report

    「In the wholesale business, by consolidating and reorganizing sales channels in conjunction with deeper penetration of regional markets, the company will actively pursue sales growth and greater awareness of its Harbour brand, as well as securing sales channels for new food products from H Plus B Life Science Co., Ltd.」

    Regional market penetration, consolidation and reorganization of sales channels, and securing sales channels for new food products continue. However, references to strengthening jointly developed products, private-label products and the OEM business, which had been included previously, have been removed.
  19. FY2018-Q3RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by the Group during the cumulative consolidated third quarter under review.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  20. FY2018-Q2RestatedAnnual report

    「There were no significant changes during the second quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  21. FY2018-Q1RestatedAnnual report

    「There were no significant changes during the first quarter cumulative consolidated period to the management policies, management strategies or other matters established by our group.」

    It states that there have been no material changes to the existing management strategy, including expansion of wholesale channels and strengthening of joint development, private-label and OEM businesses.
  22. FY2017-Q3SoftenedAnnual report

    「In the wholesale business, by consolidating and reorganizing sales channels in conjunction with deeper penetration of regional markets, the company will actively pursue sales growth and greater awareness of its Harbour brand, as well as securing sales channels for new food products from H Plus B Life Science Co., Ltd. and promoting their introduction into distribution channels. The company will also strategically leverage its product development and manufacturing capabilities to strengthen its joint development of cosmetics and food products, private-label products and OEM business.」

    The consolidation and reorganization of sales channels, the introduction of new food products, and the strengthening of joint development, private-label and OEM businesses continue. However, the reference to securing sales channels for men's cosmetics from Otokonobigaku Co., Ltd., which had been explicitly stated previously, has been removed from the current disclosure.
  23. FY2017-Q2RestatedAnnual report

    「In the wholesale business, by consolidating and reorganizing sales channels in conjunction with deeper penetration of regional markets, the company will actively pursue sales growth and greater awareness of its Harbour brand, as well as securing sales channels for new food products from H Plus B Life Science Co., Ltd. and men's cosmetics from Otokonobigaku Co., Ltd., and promoting their introduction into distribution channels. The company will also strategically leverage its product development and manufacturing capabilities to strengthen its joint development of cosmetics and food products, private-label products and OEM business.」

    The company continues to pursue the reorganization of wholesale channels, the introduction of new food products and men's cosmetics, and the strengthening of joint development, private-label and OEM businesses.
  24. FY2017-Q1RestatedAnnual report

    「In the wholesale business, by consolidating and reorganizing sales channels in conjunction with deeper penetration of regional markets, the company will actively pursue sales growth and greater awareness of its Harbour brand, as well as securing sales channels for new food products from H Plus B Life Science Co., Ltd. and men's cosmetics from Otokonobigaku Co., Ltd., and promoting their introduction into distribution channels. The company will also strategically leverage its product development and manufacturing capabilities to strengthen its joint development of cosmetics and food products, private-label products and OEM business.」

    The company continues to pursue the reorganization of wholesale channels, the introduction of new food products and men's cosmetics, and the strengthening of joint development, private-label and OEM businesses.
  25. FY2016First statedAnnual report

    「By consolidating and reorganizing sales channels in conjunction with deeper penetration of regional markets, the company will actively pursue sales growth and greater awareness of its Harbour brand, as well as securing sales channels for new food products from H Plus B Life Science Co., Ltd. and men's cosmetics from Otokonobigaku Co., Ltd., and promoting their introduction into distribution channels. The company will also strategically leverage its product development and manufacturing capabilities to strengthen its joint development of cosmetics and food products, private-label products and OEM business.」

    The company positions the reorganization of sales channels, the introduction of new food products and men's cosmetics, and the expansion of joint development, private-label and OEM businesses as an integrated wholesale growth strategy.
Moved together

"Deepening the Asian market and developing new regions and markets" moved the same way as this thread, in the same document, in 3 of its 25 moves.

322222★123456
  1. ★This thread
  2. 1Deepening the Asian market and developing new regions and markets3×
  3. 2Maximizing customer lifetime value starting with skincare products2×
  4. 3Improving brand awareness and advertising efficiency through television commercials2×
  5. 4Synergies among mail-order, store-sales and distribution businesses and optimization of sales-promotion costs2×
  6. 5Improving the earnings structure and implementing structural reforms to emerge from 3 consecutive years of losses2×
  7. 6Building the product and promotional foundation to increase the sales share of health foods2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Haba Laboratories's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.